"Medtronic’s diabetes care division suffers setback from insulin pump recall" was originally created and published by Medical ...

Medtronic announced results from a survey indicating that AI and VR could help reduce disparities in access to surgical ...

Analyst Nico Chen of DBS maintained a Hold rating on Medtronic (MDT – Research Report), retaining the price target of $90.00. Nico Chen ...

Medtronic (MDT) said it has voluntarily recalled its MiniMed 600 and 700 series insulin pumps over reports of shortened ...

The FDA approved an early feasibility study of Medtronic’s Affera mapping and ablation system and Sphere-9 catheter in ...

Medtronic in Santa Ana says its layoffs are temporary while it repairs a roof, while Avante in San Clemente wades through ...

Medtronic (NYSE: MDT) announced today that the FDA approved an early feasibility study to evaluate its Affera system for ...

Medtronic found that dropping, bumping, or hits to the MiniMed device could result in a shortened battery life.

"Make sure that when you build your products, you're thinking about it as an open platform," Nvidia's Mostafa Toloui said ...

The FDA’s Suzanne Schwartz said at The Medtech Conference that addressing legacy devices is a “work in progress” and a problem that regulators and industry need to work on together.

Many of the top large-cap device makers reported relatively rosy fourth-quarter earnings while issuing 2023 guidance that was above analyst expectations.

The company said it received 170 reports of hyperglycemia and 11 reports of diabetic ketoacidosis in the U.S. that could be linked to the problem.